Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
IDIX
|
Ag Novartis |
BUY
Open market or private purchase
|
Indirect | 1,872 Added 0.01% |
$4,512
$2.41 p/Share
|
Feb 26
2010 |
|
AYI
|
Vernon J Nagel
Executive Chairman |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.09% |
$7,900
$39.5 p/Share
|
Feb 26
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 150 Added 33.33% |
$26,850
$179.0 p/Share
|
Feb 24
2010 |
|
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Direct | 50,000 Added 3.09% |
$218,000
$4.36 p/Share
|
Feb 24
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 150 Added 50.0% |
$27,300
$182.0 p/Share
|
Feb 23
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 193 Added 1.68% |
$34,161
$177.0 p/Share
|
Feb 22
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 604 Added 36.78% |
$105,313
$174.36 p/Share
|
Feb 16
2010 |
|
FCAP
|
Chris Frederick
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 1,320 Reduced 75.82% |
$18,810
$14.25 p/Share
|
Feb 12
2010 |
|
V
|
Elizabeth Buse
EVP GLOBAL SOLUTIONS |
SELL
Open market or private sale
|
Direct | 31,599 Reduced 71.76% |
$2,662,216
$84.25 p/Share
|
Feb 12
2010 |
|
CHTT
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 923,268 Added 1.95% |
$86,325,558
$93.5 p/Share
|
Feb 11
2010 |
|
CHTT
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300,936 Added 0.66% |
$28,137,516
$93.5 p/Share
|
Feb 10
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 25.0% |
$17,066
$170.66 p/Share
|
Feb 10
2010 |
|
CHTT
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 29,417,226 Added 20.24% |
$2,750,510,631
$93.5 p/Share
|
Feb 09
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 200 Added 50.0% |
$34,304
$171.52 p/Share
|
Feb 08
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 3.4% |
$17,300
$173.0 p/Share
|
Feb 08
2010 |
|
MEI
|
Timothy Glandon
Vice President |
BUY
Open market or private purchase
|
Direct | 21 Added 0.6% |
$232
$11.04 p/Share
|
Jan 29
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,155 Added 8.28% |
$398,072
$184.72 p/Share
|
Jan 07
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 91 Added 1.43% |
$15,698
$172.5 p/Share
|
Jan 05
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 510 Added 0.09% |
$84,660
$166.0 p/Share
|
Dec 28
2009 |
|
FCNCA
|
Holding Frank B Jr
Chairman and CEO |
BUY
Open market or private purchase
|
Indirect | 510 Added 2.72% |
$84,660
$166.0 p/Share
|
Dec 28
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 400 Added 0.08% |
$65,188
$162.97 p/Share
|
Dec 24
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 104 Added 1.65% |
$17,264
$166.0 p/Share
|
Dec 22
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,175 Added 4.42% |
$196,225
$167.0 p/Share
|
Dec 18
2009 |
|
V
|
Thomas J Campbell
Director |
SELL
Open market or private sale
|
Direct | 2,958 Reduced 59.24% |
$255,897
$86.51 p/Share
|
Dec 17
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 850 Added 47.22% |
$141,950
$167.0 p/Share
|
Dec 16
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 211 Added 7.32% |
$35,026
$166.0 p/Share
|
Dec 15
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 350 Added 1.04% |
$58,100
$166.0 p/Share
|
Dec 14
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 256 Added 0.05% |
$41,554
$162.32 p/Share
|
Dec 14
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 350 Added 4.27% |
$57,750
$165.0 p/Share
|
Dec 11
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 150 Added 2.41% |
$24,900
$166.0 p/Share
|
Dec 08
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25 Added 0.0% |
$3,966
$158.65 p/Share
|
Dec 07
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 399 Added 4.34% |
$66,034
$165.5 p/Share
|
Dec 04
2009 |
|
BECN
|
Andrew R Logie
Director |
SELL
Open market or private sale
|
Direct | 15,272 Reduced 4.97% |
$247,559
$16.21 p/Share
|
Dec 03
2009 |
|
BECN
|
Andrew R Logie
Director |
SELL
Open market or private sale
|
Direct | 184,728 Reduced 37.54% |
$3,003,677
$16.26 p/Share
|
Dec 02
2009 |
|
BECN
|
Andrew R Logie
Director |
SELL
Open market or private sale
|
Indirect | 67,148 Reduced 40.17% |
$1,078,397
$16.06 p/Share
|
Dec 02
2009 |
|
FCAP
|
Samuel E Uhl
Director |
BUY
Open market or private purchase
|
Indirect | 100 Added 0.32% |
$1,521
$15.21 p/Share
|
Nov 30
2009 |
|
FCAP
|
Dennis Thomas
Senior Vice President |
SELL
Open market or private sale
|
Direct | 700 Reduced 12.37% |
$9,870
$14.1 p/Share
|
Nov 30
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 15 Added 0.0% |
$2,325
$155.0 p/Share
|
Nov 27
2009 |
|
MAS
|
Richard A Manoogian
Director |
SELL
Open market or private sale
|
Direct | 123,467 Reduced 1.92% |
$1,733,477
$14.04 p/Share
|
Nov 25
2009 |
|
SPOK
|
Brian Oreilly
Director |
SELL
Open market or private sale
|
Direct | 2,234 Reduced 38.89% |
$23,569
$10.55 p/Share
|
Nov 25
2009 |
|
FCAP
|
Dennis Thomas
Senior Vice President |
SELL
Open market or private sale
|
Direct | 200 Reduced 3.88% |
$2,900
$14.5 p/Share
|
Nov 24
2009 |
|
MAS
|
Richard A Manoogian
Director |
SELL
Open market or private sale
|
Direct | 125,679 Reduced 1.92% |
$1,780,871
$14.17 p/Share
|
Nov 24
2009 |
|
MAS
|
Richard A Manoogian
Director |
SELL
Open market or private sale
|
Direct | 854 Reduced 0.01% |
$12,152
$14.23 p/Share
|
Nov 24
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 90 Added 0.27% |
$14,670
$163.0 p/Share
|
Nov 24
2009 |
|
FCAP
|
Dennis Thomas
Senior Vice President |
SELL
Open market or private sale
|
Direct | 100 Reduced 1.98% |
$1,500
$15.0 p/Share
|
Nov 23
2009 |
|
MAS
|
Richard A Manoogian
Director |
SELL
Open market or private sale
|
Direct | 250,000 Reduced 3.68% |
$3,622,500
$14.49 p/Share
|
Nov 23
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,400 Added 19.89% |
$229,600
$164.0 p/Share
|
Nov 23
2009 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 510 Added 0.1% |
$79,050
$155.0 p/Share
|
Nov 23
2009 |
|
IOGPQ
|
R Brian Hanson
President & CEO |
SELL
Open market or private sale
|
Direct | 25,524 Reduced 24.9% |
$153,144
$6.0 p/Share
|
Nov 20
2009 |
|
IOGPQ
|
Theodore H Elliott Jr
Director |
SELL
Open market or private sale
|
Direct | 18,452 Reduced 10.76% |
$105,176
$5.7 p/Share
|
Nov 18
2009 |